Interferon-beta-1a

DRUG4 trials

Sponsors

EMD Serono, Biogen

Conditions

Hepatitis CMultiple SclerosisRelapsing-Remitting Multiple Sclerosis

Phase 3

A Multicenter Phase 3 Study of Interferon-beta-1a for the Treatment of Chronic Hepatitis C in Asian Subjects

CompletedNCT00249860

EMD SeronoHepatitis C

Start: 2002-09-30End: 2005-08-31Updated: 2013-08-06

Phase 4

Investigating if Interferon-Beta Can be Used in Patients With MS After They Have Developed Neutralizing Antibodies

CompletedNCT00492466

BiogenRelapsing-Remitting Multiple Sclerosis

Start: 2003-03-31End: 2006-08-31Updated: 2008-01-30

Simvastatin as an Add-on Treatment to Interferon-beta-1a for the Treatment of Relapsing-Remitting Multiple Sclerosis

CompletedNCT00492765

BiogenMultiple Sclerosis

Start: 2006-02-28End: 2010-04-30Updated: 2010-10-15

Is IFN-beta Treatment in MS Useful After a Washout Period in Patients With Neutralizing Antibodies to Interferon Beta

CompletedNCT00493116

BiogenRelapsing-Remitting Multiple Sclerosis

Start: 2003-10-31End: 2009-12-31Updated: 2013-09-16

Related Papers

Simvastatin as add-on therapy to interferon β-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial.

2011-08-0188 citations